
Hans Theiss
Hans Diogenes Theiss (born 20 September 1977 in Munich) is a German physician and a politician of the Christian Social Union in Bavaria (CSU).
- Facts0
- Drivers0
- Indicators0

Hans Diogenes Theiss (born 20 September 1977 in Munich) is a German physician and a politician of the Christian Social Union in Bavaria (CSU).
Hans Diogenes Theiss (born 20 September 1977 in Munich) is a German physician and a politician of the Christian Social Union in Bavaria (CSU). He has been a member of the Bundestag since the constituent sitting of the 21st electoral term on 25 March 2025, holding the direct mandate for constituency 216, Munich-North, and sitting in the CDU/CSU parliamentary group.
Theiss took his Abitur at the Wilhelmsgymnasium in Munich and, in 1996–97, completed basic military service as a Gebirgsjäger in Mittenwald. From 1997 to 2003 he studied human medicine at the Ludwig Maximilian University of Munich, which awarded him a doctorate in 2003 and, in 2010, the habilitation (teaching qualification) in internal medicine. Since 2013 he has been an Oberarzt in Medical Clinic I of the University of Munich Hospital and a specialist in internal medicine, cardiology and internal intensive-care medicine; in 2016 he received a professorship in internal medicine at the university. He kept a reduced clinical post after entering parliament. Disclosures filed with the Bundestag list gross pay from the university hospital of €27,597.90 in 2025 and €23,282.20 in 2026.
He joined the CSU in 2002. From 2014 to 2025 he was a member of the Munich city council and health-policy spokesman of its CSU group. Since 2014 he has belonged to the CSU’s Munich Bezirksvorstand; since 2016 he has chaired the Kreisverband Munich-Mitte; and since 2019 he has chaired the party’s Munich working group on health and care policy. In July 2024, delegates of the CSU in Munich-North chose him on the first ballot, with 80 of 152 votes, ahead of the sitting member of parliament Bernhard Loos.
At the federal election of 23 February 2025 he received 59,875 first votes (32.4 percent), 6.7 percentage points above the CSU’s 2021 share in the constituency, ahead of Frederik Ferid Ostermeier of Alliance 90/The Greens (44,708 votes, 24.2 percent). Turnout was 83.0 percent among 223,701 eligible voters. In the 21st Bundestag he is a full member of the Committee on Health and of the Committee on Research, Technology, Space and Technology Assessment, and a deputy member of the Petitions Committee. The Bundestag biography, which rests on the member’s own disclosures, states that he is married and has one child.
Hans Diogenes Theiss was born on 20 September 1977 in Munich. The German Bundestag’s member biography records that date and birthplace, and states that its biographical text rests on information supplied by the member. In the Federal Returning Officer’s register for the Bundestag election of 23 February 2025 he is listed as Dr. Theiss, Hans Diogenes, born in 1977, with the occupation physician (Arzt).
From 1983 to 1996 he attended primary school and took the Abitur at the Wilhelmsgymnasium in Munich. The Bundestag biography gives that span and does not name the primary school.
The Staatliche Wilhelmsgymnasium presents itself as Munich’s oldest Gymnasium. Duke Albrecht V founded it in 1559 as a Paedagogium, in the school’s words “not merely an ordinary children’s school,” and the Jesuits directed it until the suppression of the order in 1773. It received the name Wilhelmsgymnasium in 1849 after Duke Wilhelm V, whom the school calls its reputed founder. In 1877 it moved into the neo-Renaissance building at the Maxmonument, on Thierschstraße, which the school identifies as Munich’s oldest school building and as part of the Maximilianstraße ensemble. Its own history stresses a Jesuit tradition of humanist learning, later literary and educational influence—including the neo-Latin writers Jakob Bidermann and Jakob Balde and the school reformer Friedrich Wilhelm Thiersch—and an old library that still holds early printed books. As a humanist Gymnasium it teaches Latin from year 5, and Greek as a core subject, with grammar, vocabulary and translation in years 8 to 10. The biography records only that he took his Abitur there, not his subjects or marks.
After leaving school, Theiss performed basic military service (Grundwehrdienst) from 1996 to 1997 as a Gebirgsjäger in Mittenwald. On his own site he describes the period as a year of military service in the town.
From 1 January 1996 the Wehrrechtsänderungsgesetz shortened compulsory basic service in the Bundeswehr from twelve months to ten, followed by two months of standby availability (Verfügungsbereitschaft), during which conscripts could be recalled. The Bundestag’s later survey of conscription records the further cuts to nine months in 2002 and to six months in July 2010, and the suspension of compulsory call-up on 1 July 2011.
Mittenwald, in Bavaria, is the station of Gebirgsjägerbataillon 233, mountain infantry of the army’s Gebirgsjägerbrigade 23. The battalion was formed in 1981 from Gebirgsjägerbataillon 221 and is based at the Edelweiß-Kaserne; the Bundeswehr describes the Gebirgsjäger as combat troops trained for mountain, high-altitude and extreme-weather operations. Theiss’s accounts name the branch and the town, not a company or battalion.
From 1997 to 2003 Theiss studied human medicine at Ludwig Maximilian University of Munich (Ludwig-Maximilians-Universität München). In 2003 the university awarded him the doctorate (Promotion).
The medical faculty grants the degree Dr. med. (Doktor der Humanmedizin) as a research doctorate, with a dissertation and a defence. Under the faculty’s present rules, domestic candidates are admitted after the first state medical examination, and the dissertation may be written in German or English. Those provisions describe the current procedure, not necessarily the doctoral ordinance under which a thesis was accepted in 2003. The Bundestag biography records the Promotion but does not give the title or subject of the dissertation.
Hans Theiss's path from medical graduate to senior cardiologist is documented through appointments and academic qualifications rather than a published training log. After his doctorate at the Ludwig Maximilian University of Munich (LMU) in 2003, a 2006 publication already gave his address as Medical Clinic and Polyclinic I of LMU at Klinikum Großhadern in Munich. In 2010 he completed a Habilitation at LMU, receiving the Lehrbefugnis, the authorization to teach, in internal medicine.
The Bundestag biography, which the parliament states is drawn from members' own information, records that since 2013 he has been an Oberarzt—a senior physician—at Medical Clinic I, and a Facharzt, the German specialist qualification, in internal medicine, cardiology and internal intensive care medicine. Deutsches Ärzteblatt gave the same account in a 2025 profile, describing him as a Munich cardiologist who had worked as a senior physician and cardiology specialist since 2013. Those biographies do not date the individual specialist certificates, so it is not clear from them whether each Facharzt title was granted in 2013 or earlier.
Medical Clinic and Polyclinic I of LMU Klinikum—the university hospital, also named in parliamentary disclosures as the Klinikum der Universität München—works at the Großhadern and city-centre campuses. Its cardiology outpatient clinic at Großhadern is at Marchioninistraße 15. The clinic's team page lists Theiss as Prof. Dr. med. Hans Theiss, Oberarzt.
The department states that its clinical work covers interventional cardiology: cardiac catheterization, coronary balloon dilatation and stent implantation, treatment of myocardial infarction, and catheter procedures on the aortic, mitral and tricuspid valves, including transcatheter aortic valve implantation (TAVI). It also says the German Cardiac Society (Deutsche Gesellschaft für Kardiologie) recognizes the clinic as a TAVI centre, and it lists acute and chronic heart failure, rhythm disorders and internal intensive care among further activities. Those statements describe the service. They do not identify which procedures Theiss himself performs, and his parliamentary biography does not name a personal interventional focus.
The clinic does name him in connection with intensive-care training at Großhadern. Together with Prof. Dr. med. Stefan Kääb, he is listed as authorized to provide the additional qualification in intensive-care medicine (Zusatz-Weiterbildung Intensivmedizin), with a full authorization of 24 months under the 2004 training regulations (Weiterbildungsordnung). The same page ties that authorization to the cardiological intensive care unit on the Großhadern campus, which it says the Bavarian Medical Association recognizes, and describes the unit's work on cardiogenic shock, including temporary heart-lung support with veno-arterial ECMO, as a focus of the clinic rather than of one physician.
In 2016 Theiss took up a professorship in internal medicine at LMU. Neither the disclosure nor the hospital listing states whether that appointment is an außerplanmäßige (supernumerary) professorship or a salaried W2 or W3 chair. He continues to be identified as an Oberarzt, and the clinic names Prof. Dr. med. Steffen Massberg, not Theiss, as its scientific head.
The occupation he declared for the period before his Bundestag membership, which began on 25 March 2025, was Oberarzt at the Klinikum der Universität München. He kept that paid post alongside the mandate. The gross sums published with the declaration under the parliament's rules of conduct are 27,597.90 euro for 2025 and 23,282.20 euro for 2026. Members must file reportable outside activities within three months of taking their seats, and again within three months of any change; the Bundestag publishes a figure only after checking that disclosure is required. The two amounts are the declared gross receipts for the senior-physician post alongside the mandate, not a published figure for a previous full-time hospital salary. On 22 May 2025 Tagesspiegel Background reported that the Christian Social Union member of parliament was allowed to continue the senior-physician job at LMU Klinikum Großhadern at 20 percent of full time and did not have to give up operating (Operieren).
Hans D. Theiss co-authored studies of cytokine mobilization of bone-marrow progenitor cells after myocardial infarction, an alternative to injecting or infusing cells. With Markus G. Engelmann and Wolfgang-Michael Franz at Medical Clinic I, Klinikum Großhadern (LMU Klinikum, Ludwig Maximilian University of Munich), he was second author of G-CSF-STEMI, an investigator-initiated, randomised, double-blind, placebo-controlled phase II study published in 2006 in the Journal of the American College of Cardiology. Forty-four patients with subacute ST-segment elevation myocardial infarction and delayed percutaneous coronary intervention received granulocyte colony-stimulating factor (G-CSF) or placebo for five days after successful PCI; the one-year report of the trial specifies filgrastim at 10 µg/kg/day. Primary endpoints were the change in global and regional myocardial function on cardiac magnetic resonance imaging from one week to three months.
G-CSF mobilized endothelial progenitor-cell populations and improved infarct perfusion at one week and one month, but the change in global ejection fraction was 6.2 ± 9.0% with G-CSF versus 5.3 ± 9.8% with placebo (p = 0.77), and regional function did not differ significantly. Revascularization for in-stent restenosis and major adverse cardiovascular events were comparable. The authors called treatment feasible and relatively safe, and concluded that patients did not benefit when PCI was performed late.
At 12 months, ejection fraction in the G-CSF group had moved from 41.1 ± 11.9% at baseline to 47.1 ± 11.9% at three months and 45.7 ± 15.1% at one year, and in the placebo group from 43.8 ± 9.0% to 49.5 ± 11.8% and then 42.9 ± 15.4%, without a significant difference at any time; one-year MRI was available for 23 of 44 patients. Infarct size, perfusion, ventricular volumes and event-free survival also did not differ, and the follow-up concluded that G-CSF alone did not improve function or survival after subacute infarction with late revascularization. A 2008 post-hoc analysis, with MRI in 37 patients, found that G-CSF started within 24 hours of PCI (13 patients; mean 16 ± 6 hours) improved resting perfusion at one month compared with placebo, whereas later treatment (10 patients; mean 49 ± 26 hours) did not, and that timing did not change global or regional function.
The same Munich laboratory then tested whether preserving a homing signal would add what G-CSF alone had not shown. In a 2009 Cell Stem Cell paper, Marc-Michael Zaruba and Theiss, with Franz as last author, combined genetic or pharmacologic inhibition of CD26/dipeptidyl peptidase IV with G-CSF in mice after infarction. Because the enzyme cleaves stromal cell-derived factor 1 (SDF-1), inhibition was intended to maintain the SDF-1–CXCR4 axis that draws circulating progenitors into ischaemic muscle. The combination lowered myocardial DPP-IV activity, increased cardiac homing of CXCR4-positive cells, limited remodelling, and improved ventricular function and survival; the authors proposed it for later clinical stem-cell trials.
In 2010 Theiss, Christoph Brenner, Franz and colleagues published the design of SITAGRAMI (sitagliptin plus granulocyte colony-stimulating factor in acute myocardial infarction) and a first safety interim analysis, citing that preclinical work. It was planned as a phase III, multicentre, randomised, placebo-controlled trial (EudraCT 2007-003941-34) of 100 patients, with regeneration inferred from MRI measures of cardiac function. Among the first 36 patients over six weeks, the only major adverse cardiac events were one new stenosis and one in-stent restenosis, presumed unrelated to study drug; the report recorded no death, recurrent infarction, headache, bone pain or hypoglycaemia in that window. The registry record, sponsored by LMU Munich, lists a quadruple-blind phase II/III trial running from March 2008 to June 2013, with primary completion in June 2012 and 174 participants enrolled. After PCI performed 2 to 24 hours from symptom onset, the active arm was lenograstim 10 µg/kg/day subcutaneously for five days plus sitagliptin 100 mg orally for 28 days. In a related 2013 mouse study, Theiss was first author and Franz last author: sitagliptin and the DPP-IV inhibitor vildagliptin, especially with G-CSF, improved homing, function and survival, which the authors read as a possible class effect in that model.
The 2016 efficacy paper, Brenner first author and Theiss last author, randomised 174 patients 1:1, including people with and without diabetes, with funding from the Heinz Nixdorf Foundation. The primary endpoint hierarchically combined the changes in global left- and right-ventricular ejection fraction from baseline to six months on cardiac MRI. Neither change differed between G-CSF plus sitagliptin and placebo, and the risk of a major adverse cardiac event within 12 months was similar. The authors concluded that the combination after successful revascularization failed to show a benefit for cardiac function or clinical events at 12 months.
On longer follow-up, median 4.50 years (interquartile range 3.56–5.95), death, myocardial infarction or stroke occurred in 12.8% of the placebo group and 9.2% of the combination group (hazard ratio 0.69, 95% CI 0.28–1.69; p = 0.42). A combined cardiovascular outcome occurred in 47.7% and 41.4% (HR 0.75, 95% CI 0.48–1.18; p = 0.21), and MACCE rates did not differ significantly (p = 0.41).
The Bundestag biography, which states that its details rest on the member’s own information, records a habilitation at LMU in 2010 conferring the teaching licence (Lehrbefugnis) in internal medicine, and a professorship in internal medicine there in 2016. Franz is the last author of the G-CSF-STEMI reports, the 2009 mouse study, the 2010 SITAGRAMI design paper and the 2013 gliptin experiments; Brenner, Engelmann, Zaruba and Stefan Brunner are recurring co-authors.
A PubMed query for the author string “Theiss HD” returns 42 indexed records, from a 2002 gene-transfer paper in chronic lymphocytic leukaemia to 2025 imaging after transcatheter aortic-valve replacement, including the progenitor-cell series and later work on shock support and coronary scaffolds. SITAGRAMI, the randomised test of the combined regimen, did not show a gain in ejection fraction or clinical events.
Hans Theiss joined the Christian Social Union in Bavaria (CSU) in 2002. In the biography he supplied to the Bundestag, he states that he has been a member of the executive of the CSU's Munich district association (Bezirksverband) since 2014, chairman of the Kreisverband München-Mitte since 2016, and, since 2019, Bezirk chairman of the party's health and care working group in Munich, the Gesundheits- und Pflegepolitischer Arbeitskreis (GPA).
The Kreisverband, listed by the party as Kreisverband München I, describes its area as running from the Rotkreuzplatz in Neuhausen to the Altstadt and from the Schwanthalerhöhe across the Isar into the Au, taking in the Ludwigsvorstadt, the Isarvorstadt, the Gärtnerplatzviertel, the Maxvorstadt and the area around the Josephsplatz. It is organised in eight local branches (Ortsverbände), and its website names Theiss as Kreisvorsitzender.
On 12 June 2023 members of the GPA Bezirksverband München met at the CSU district office in the Adamstraße. Theiss, already Bezirksvorsitzender, reviewed the previous two years and was confirmed in office; Christian Bredl, head of the Techniker Krankenkasse in Bavaria, and Manuela Ohlhausen were re-elected as deputies, and Antonia Waldner was elected a deputy for the first time.
Theiss's Bundestag biography records him as a Munich city councillor from 2014 to 2025 and as health-policy spokesperson of the CSU council group. The election was held on 16 March 2014. In the official final result the CSU received 11,111,791 votes, 32.5 percent, and 26 of the council's 80 seats, four more than in 2008, and was the largest group; 456,896 of 1,087,404 eligible voters took part, a turnout of 42.0 percent.
Bavarian communal ballots allow voters to cumulate votes on one candidate and to split them across lists, so the order of those elected follows personal votes rather than the printed list order. A list the Münchner Merkur published on 19 March 2014 from the city's election pages, while the count was still described as preliminary, placed Theiss 21st among CSU candidates with 151,212 votes, inside the 26 places the party filled.
For the election of 15 March 2020 the election committee admitted him in fourth place on the CSU list, behind Kristina Frank, Manuel Pretzl and Evelyne Menges. The official final result, established on 2 April 2020, gave the CSU 9,986,014 votes and 20 seats. Alliance 90/The Greens finished ahead, with 11,762,516 votes and 23 seats, and 544,464 of 1,110,571 eligible voters cast ballots. Theiss received 159,568 personal votes and was seated third among the CSU members, ahead of Menges, who had 156,911.
On 8 January 2018 the CSU council group elected him a deputy chairman in succession to Michael Kuffer, who had entered the Bundestag the previous autumn. The Abendzeitung reported that he was then the group's spokesperson on finance and on health, and that he joined Menges and Kristina Frank in supporting the group chairman, Manuel Pretzl. In 2025 the city press office identified his group as the council group of the CSU with the Free Voters. The disclosure published by the Bundestag records his council membership as ending on 31 May 2025 and states a monthly gross payment of 4,819.00 euros for that office.
At the plenary of 28 May 2025, which the city press office described as the last sitting for both, Bürgermeister Dominik Krause presented Theiss and the Green councillor Anna Hanusch with the silver medal "München leuchtet – Den Freundinnen und Freunden Münchens", in recognition of services to the city. The tz reported that Krause was standing in for Oberbürgermeister Dieter Reiter, and that both councillors had sat since 2014.
The city has awarded the medal since 1961, in gold, silver or bronze, for particular services to Munich. Its motto is taken from the opening of Thomas Mann's novella Gladius Dei; apart from certain routine cases, the Oberbürgermeister confers it in agreement with the council's Ältestenrat.
The same plenary confirmed the two successions. Theiss left the council after that day, following his election to the Bundestag, and Michael Haberland took the vacant seat in the CSU/Free Voters group. Hanusch was to resign on 30 June 2025 to become head of the department for the environment, urban green space and building construction in Braunschweig; Linda Faltin succeeded her in the Greens–Rosa Liste group.
As health-policy spokesperson for the Christian Social Union (CSU) on the Munich city council, Theiss spent much of 2014–2025 on München Klinik, one of Germany's largest municipal hospital groups. In May 2019 the Social Democratic Party (SPD) and the CSU agreed to make it a non-profit company from 1 January 2020 and to drop lower-paid service subsidiaries; CSU mayor Manuel Pretzl said his party had helped negotiate the deal. Katrin Habenschaden of Alliance 90/The Greens called the reversal a zigzag, and FDP leader Michael Mattar a distraction that still left taxpayers funding a restructuring he said was failing.
In July 2020 Theiss called the clinics the "heart of municipal services of general interest" and said only great effort had averted insolvency in 2014; the CSU sought more equity from 2021 so building could continue. By May 2021 the Abendzeitung reported a gap of at least €365.2 million, with Bogenhausen, Harlaching and Schwabing costed at about €1 billion, €136 million over the 2020 assumption. The council had the company borrow €141.1 million and the city add €224.1 million. Theiss wanted the city to put up the capital, asking what would happen if it had by then been spent on "favourite projects such as cycle paths"; SPD councillor Klaus Peter Rupp said borrowing was normal for municipal companies and that unlimited subsidies would breach European competition law.
Theiss sat on the supervisory board. In January 2023 a concept under discussion since mid-2020, including possible bed cuts and merged departments, was pulled so a successor to chief executive Axel Fischer could reshape it; Theiss called the delay bitter and said emergency bottlenecks still needed answers. His question of 15 December 2022, published by the city as "Is München Klinik sinking into green-red chaos?", cited a rising deficit, construction trouble at Bogenhausen and Schwabing, and secrecy about risk, and asked whether Lord Mayor Dieter Reiter, the board's chair, still had the company under control. Health commissioner Beatrix Zurek replied that Fischer told Reiter in early December he would not renew, that staffing policy had not failed, and that closing a site was for the full council.
On 18 July 2024 the health committee passed a new concept against the CSU with the Free Voters, the FDP/Bavaria Party and the ÖDP/Munich List. Bogenhausen and Harlaching were to stay maximum-care hospitals; emergency care at Schwabing and Neuperlach was to drop from level two to level one, against a deficit the Süddeutsche Zeitung put near €100 million. Theiss had "considerable doubts" about cutting Schwabing, above all for heart attacks if a federal reform closed other hospitals, and said the economic case had been omitted. Stephan Prückner of the LMU emergency-medicine institute said heart-attack care would hold. Neuperlach midwives had protested for eighteen months against moving births to Harlaching, which CSU councillor Alexandra Gaßmann called fatal if not negligent; the SPD, Greens and Left insisted employed and freelance midwives share a delivery suite. When Theiss left on 28 May 2025, Pretzl said the turnaround "would not have succeeded without you" — a faction leader's judgement, not an audit. That October the works council warned Reiter that "haphazard job cuts" endangered patients and doctors, as annual losses ran into the hundreds of millions.
Theiss's Bundestag side-income filing lists seats still held after March 2025 and the gross sums booked for that year. He stayed on the supervisory board of Stadtwerke München GmbH until 29 April 2025 (€2,000 recorded) and of subsidiary SWM Services GmbH until the same day, with no separate fee. The Stadtwerke 2024 report lists him on the board chaired by Reiter; the board received €47,000 that year. He also sat on the board of München Klinik Bau Projektgesellschaft mbH until 28 May 2025 (€1,500). The filing records a further €4,200 from the City of Munich for the jury of the "Ideenwerkstatt München Norden".
During the COVID-19 pandemic Theiss broke with Minister-President Markus Söder. After Bavaria declared a disaster and tightened Christmas rules, a Facebook letter reported on 7 December 2020 said party loyalty had kept him silent "but enough is enough", and that policy needed "less Herrenchiemsee and more honesty and political accuracy". He wrote that COVID-19 was worse than influenza, but that care homes lacked a testing regime, ventilators were not matched by intensive-care nurses, 75 percent of infection chains went untraced, and the Christmas rules were heartless. More people, he believed, were dying because of the pandemic than of the virus, and lockdowns plus the AHA rules were not enough.
CSU general secretary Markus Blume said Theiss had been wrong from the start, citing an April call for "controlled infection", a strategy Blume said had failed worldwide, and called the deaths claim dangerous and blind to intensive care. The Hessische/Niedersächsische Allgemeine reported a mid-April 2020 post on the same profile urging controlled spread toward herd immunity. Munich CSU chair Ludwig Spaenle respected the opinion of an experienced cardiologist, "but it is not ours".
Theiss won the Christian Social Union in Bavaria (CSU) nomination for Bundestag constituency 216, München-Nord, against the sitting member. Bernhard Loos, in the Bundestag since 2017, wrote to members that he was available "letztmalig" — for a last time — and the Münchner Merkur reported that he was still treated as the safe candidate when challengers appeared.
Florian Post, a former Social Democratic Party of Germany member of the Bundestag who had joined the CSU in 2022, was urged by delegates in mid-May 2024 to stand. On 17 June he withdrew. He told the Kreisvorstand he would not start an "innerparteilichen Wettstreit" with Loos, a former colleague with whom he had got on, and that the CSU needed the greatest possible unity for the election. Loos called the withdrawal a "sehr noble Geste".
Theiss, then deputy leader of the CSU group on the Munich city council, applied soon afterwards. The Merkur reported that he had left a possible CSU candidacy for mayor in 2026. In a June letter he wrote that many matters affecting Munich were decided in Berlin, which motivated him to take responsibility federally, and that 20 years in the constituency had familiarised him with its local issues.
The delegates' assembly on 23 July 2024 decided it on the first ballot: 80 votes for Theiss, 63 for Loos and six for Matthias Asmussen, at a meeting the Merkur put at 152 delegates. Theiss called the result an honour and an incentive, thanked both rivals for a fair contest, and said he wanted to win the seat for the CSU. He named health policy, including nursing shortages and patients' interests, control of immigration, and an affordable, secure energy supply as his priorities.
Constituency 216 consists of six boroughs of the city of Munich: 3 (Maxvorstadt), 4 (Schwabing-West), 10 (Moosach), 11 (Milbertshofen-Am Hart), 12 (Schwabing-Freimann) and 24 (Feldmoching-Hasenbergl). The remaining boroughs are in constituencies 217 (München-Ost), 218 (München-Süd) and 219 (München-West/Mitte).
Map of Munich's Bundestag constituencies for the 2025 federal election, including constituency 216 München-Nord.
That assembly chose a candidate for a poll then fixed for 28 September 2025. On 27 December 2024 the Federal President, at the chancellor's request, dissolved the 20th Bundestag and set the election for Sunday, 23 February 2025, compressing the constituency campaign into the weeks after Christmas.
The admitted nominations placed Theiss, a physician, against Philippa Sigl-Glöckner (SPD; an economist), Frederik Ferid Ostermeier (Alliance 90/The Greens; a production-digitalisation specialist) and Daniel Föst (Free Democratic Party; a sitting member of the Bundestag). Also admitted were Christoph Rätscher (Alternative for Germany), Linus Springer (Free Voters), Christian Schwarzenberger (Die Linke), Marco Heumann (Volt Germany) and Gerhard Hager (Bündnis Deutschland). Theiss campaigned as the CSU direct candidate on the priorities he had stated after the nomination.
In the final result, 185,631 of 223,701 eligible voters took part, a turnout of 83.0 per cent, 4.5 points above 2021. Of 184,655 valid first votes, Dr Hans Diogenes Theiss (CSU) received 59,875 (32.4 per cent, up 6.7 points) and was elected in the 2025 German federal election. Ostermeier was runner-up with 44,708 (24.2 per cent, unchanged). The SPD took 36,495 (19.8 per cent, down 2.1), the AfD 16,684 (9.0, up 4.7), Die Linke 12,123 (6.6, up 3.0), the FDP 8,536 (4.6, down 6.5), Volt 3,010 (1.6, up 0.3), the Free Voters 2,700 (1.5, down 0.8) and Bündnis Deutschland 524 (0.3).
Of 185,147 valid second votes, the CSU led with 53,509 (28.9 per cent, up 6.0), ahead of the Greens on 42,291 (22.8, down 2.8), the SPD on 28,469 (15.4, down 3.6), the AfD on 17,688 (9.6, up 4.8), Die Linke on 16,785 (9.1, up 5.0) and the FDP on 12,394 (6.7, down 8.1). The Bündnis Sahra Wagenknecht, with no constituency candidate, received 6,075 (3.3 per cent). Those shifts put the CSU ahead of the Greens on the party vote; on first votes the CSU had already led the Greens in the constituency in 2021.
A 2023 reform seats a party candidate only with a first-vote plurality that the party's second-vote allocation in the Land also covers. Constituencies a party wins beyond that allocation, those with the lowest first-vote shares, stay empty, and overhang seats are abolished. Second votes allocate the Bundestag's 630 seats. In Bavaria the CSU led all 47 constituencies but, with 37.2 per cent of the Land's second votes and 6.0 per cent nationwide, received 44 seats. The Merkur named Sebastian Brehm (Nürnberg-Nord), Claudia Küng (München-Süd) and Volker Ullrich (Augsburg-Stadt) as the three plurality winners left out. Theiss's was seated: the Bundestag records a Wahlkreismandat for constituency 216. The 21st Bundestag constituted itself on 25 March 2025.
Theiss has been a member of the 21st Bundestag since 25 March 2025, the day that parliament constituted itself. He holds the direct constituency mandate (Wahlkreismandat) for constituency 216, München-Nord, in Bavaria, and is listed in the CDU/CSU parliamentary group with the occupation physician (Arzt). His Bundestag office is at Platz der Republik 1, 11011 Berlin; the constituency office is at Adamstraße 2, 80636 Munich.
He is a full member of the Committee on Research, Technology, Space and Technology Assessment (Ausschuss für Forschung, Technologie, Raumfahrt und Technikfolgenabschätzung) and of the Committee on Health (Ausschuss für Gesundheit), and a deputy member of the Petitions Committee (Petitionsausschuss). The Bundestag biography lists no further parliamentary body for him. Inside the Christian Social Union Landesgruppe, the CSU’s group within the CDU/CSU, he is fachpolitischer Sprecher for research and technology (Forschung und Technologie). That title is an appointment of the party group, not an office of the Bundestag. The Landesgruppe says its specialist spokespersons are the full and deputy members of the Bundestag committees that correspond to their fields, and that the CSU group as a whole decides the political line.
The Members of the Bundestag Act (Abgeordnetengesetz) places exercise of the mandate at the centre of a member’s activity but treats professional or other work alongside the mandate as generally permissible. Since a reform that took effect on 19 October 2021, the code of conduct has formed the eleventh section of that act (§§ 45 ff.). Members must notify the President of their last occupation, paid activities beside the mandate, functions in companies and in public-law corporations and institutions, and certain other interests, including posts in associations and foundations. Income from a notifiable activity is published to the cent if it exceeds 1,000 euros in a month or, if not, 3,000 euros in a calendar year. Notices are due within three months of taking the seat and within three months of any later change, and they appear on the member’s biography once the administration has checked what must be published. The Bundestag states that the disclosures are intended to let voters assess possible conflicts of interest and the independence of each member.
Theiss’s published return, current on the biography as of 27 October 2026, records his occupation before the mandate as senior physician (Oberarzt) at the LMU Klinikum in Munich, and the continuation of that employment for gross pay of 27,597.90 euros in 2025 and 23,282.20 euros in 2026. Company functions that ended in spring 2025 are also listed: membership of the supervisory board of München Klinik Bau Projektgesellschaft mbH until 28 May 2025, with 1,500.00 euros gross in 2025; of Stadtwerke München GmbH until 29 April 2025, with 2,000.00 euros gross in 2025; and of SWM Services GmbH until 29 April 2025, for which no amount is published. Under functions in public-law bodies, the return lists membership of the Munich city council until 31 May 2025 at 4,819.00 euros gross a month, and membership of the jury of the Ideenwerkstatt München Norden, shown as 4,200.00 euros gross in 2025.
The address on Adamstraße is the constituency office published for Wahlkreis 216. In the plenary he spoke for the CDU/CSU on 25 June 2025 in a current-affairs hour on the report of the special representative for mask procurement, referring to hospital intensive-care work in 2020. On 11 September 2025 he spoke in the current-affairs hour “Hightech Agenda Deutschland – Mit Höchstleistungen in Forschung und Innovation Deutschland voranbringen,” requested by the CDU/CSU and the SPD, after Federal Research Minister Dorothee Bär. On 23 September 2025 he spoke in the debate on Einzelplan 15, the budget of the Federal Ministry of Health. The Bundestag biography page links to the collected record of his speeches and of his votes in roll-call divisions.
On 21 November 2025 he visited the Oberpfaffenhofen site of the German Aerospace Center. The centre reported that he was briefed on preparations and operations for space missions at the German Space Operations Center, on satellite-data products, including for crises, at the German Remote Sensing Data Center, on protection against jamming and spoofing of satellite navigation, on radar in Earth observation, and on robotics transfer projects.
In his first months in the Bundestag, Hans Theiss of the Christian Social Union in Bavaria spoke for the CDU/CSU mainly on emergency care, transplantation and statutory-insurance finance. Debates and group statements from 2025 and 2026 do not show a comparably specific case by him for leaving diagnosis-related group hospital payment, or a developed federal argument on nursing shortages.
On 16 October 2025, at the first reading of an emergency-care bill from Alliance 90/The Greens, he said a government reform was already in preparation and that the rescue service was hopelessly overloaded. He called the opposition text “old traffic-light wine in new bottles”. SPD health politician Tanja Machalet pressed for one coherent reform after what she called ten years of discussion. In January 2026 Deutsches Ärzteblatt reported him saying, at an AOK event, that a primary-care system would not yield relevant short-term savings and that an emergency reform would save only “one to two billion” euros over the following years. Patients, he said, would have to share responsibility with industry and providers.
On 15 October 2026 he called the government’s emergency law a “quantum leap”: 112 linked to 116 117, preferably through the electronic patient record and artificial intelligence; statutory finance for rescue services; integrated centres reachable by 98 percent of the population within 30 minutes by car; and savings he put at 1.2 billion euros a year. Earlier, at a hearing on 9 September 2026, the National Association of Statutory Health Insurance Physicians largely rejected the draft as parallel structures paid from budgeted fees, and the German Medical Association warned against several steering systems at once.
On transplantation he has spoken as a physician. On 26 March 2026 he welcomed anonymous cross-over living kidney donation, which he said could help several hundred people a year. On 24 September 2026 he co-sponsored an opt-out bill for deceased organ donation, citing about 600 to 700 waiting-list deaths a year and studies he said showed higher rates under opt-out. Neighbours and the other Eurotransplant members already used that rule, he argued, while Germany ranked 22nd. The draft, he said, kept the brain-death standard. Speakers from the CDU/CSU, the SPD, the Greens and The Left backed the bill; CDU colleague Michael Brand said silence must not count as consent.
As CSU spokesperson on research, technology and space, Theiss has argued the Hightech Agenda of Research Minister Dorothee Bär. On 11 September 2025 he named six fields in which he said Germany could lead: artificial intelligence and quantum technology, microelectronics, biotechnology including CRISPR editing and a national biobank, climate-neutral mobility, and fusion. At the motor show in his Munich constituency he said the 2035 European ban on new combustion-engine cars would have to go if e-fuels were to be used, and he called a first German fusion reactor “the German Moon landing”. AfD speaker Stefan Schröder cited industrial electricity prices and the nuclear exit; Left member Sonja Lemke said fusion would come too late for the climate.
On 22 April 2026 Bär told him the national biobank should advance within weeks or months. The same day he cited 5.4 billion euros subscribed to the European Space Agency and the aim that a German astronaut be the first European on the Moon, and he named Rocket Factory Augsburg and Isar Aerospace as a new generation of launchers. Greens speaker Ayse Asar asked for European rules; AfD speaker Nicole Höchst credited private firms rather than public subscriptions. After Spectrum reached orbit, Theiss said on 7 September 2026 that the flight was a milestone for Germany as a space location and tied it to Bär’s agenda.
On 14 November 2025 he welcomed 50 million euros in the 2026 budget as the start of a ten-year programme, which he said should total half a billion euros, on post-COVID conditions, myalgic encephalomyelitis/chronic fatigue syndrome and post-vaccination syndromes. On 24 September 2026 he backed an amendment to the Scientific Freedom Act letting non-profit institutes that are not institutionally funded by the federation set pay from private money without an exemption application.
Beyond those briefs the federal record is thinner. In January 2026 Theiss told Bild, as reported by Der Tagesspiegel and the Bayerische Staatszeitung, that about two euros more tobacco tax per pack could finance cutting value-added tax on medicines from 19 to 7 percent and give statutory insurers up to seven billion euros a year. Drugs commissioner Hendrik Streeck, former health minister Karl Lauterbach and the DAK fund were already discussing similar ideas; his figure was a proposal, not a bill he had carried by autumn 2026. Migration does not appear in the plenary speeches examined here. The Ärzteblatt and Bayerischer Rundfunk relayed the health positions without a separate controversy over his federal record.
The Bundestag biography of Hans Theiss, born in Munich on 20 September 1977, states that he is married and has one child, without naming either. His wife is the physician Christine Theiss (née Hennig), born Christine Anna Maria Hennig on 22 February 1980 in Greiz. Her parents, both doctors, left East Germany in 1984 and settled in Bayreuth.
They met at the LMU Klinikum in Großhadern during a joint research project, she as a doctoral student and he as an assistant physician. Bild described a church wedding in 2005; the Ärzte Zeitung dated the marriage to December of that year. Christine Theiss studied medicine at the Ludwig Maximilian University of Munich, passed the state examination in November 2007 and received her doctorate in December 2008, but did not take up clinical practice. In kickboxing she won an amateur world title in 2005 and, on 25 May 2007 in Vilamoura, a professional title of the World Association of Kickboxing Organizations. She stopped competing at the end of 2013 while still a champion. From 4 March 2012 she presented The Biggest Loser Germany on Sat.1.
On Saturday, 16 April 2016, she wrote on Facebook that their daughter, Cosima, had been born; the Abendzeitung reported the announcement the next day. The family lives in Schwabing. In 2013 Christine Theiss said she had already lived in the district for about five years, and later coverage described the parents as keeping their daughter out of the press.
In the official result of the Bundestag election of 23 February 2025 he is listed as Dr. Hans Diogenes Theiss of the Christian Social Union. The parliamentary biography gives his family circumstances only as “verheiratet; ein Kind”.
Away from the hospital and his political offices, Theiss has drawn less personal coverage than his wife, whose sporting career was already a Munich media subject before his own elected offices. In the summer of 2008 she received the Bavarian Sports Prize from Minister-President Günther Beckstein. Abendzeitung readers voted her the city’s sportswoman of the year for a seventh time in January 2014, after she had announced her retirement from the ring the previous December. Bild reported a joint appearance at the 2019 Munich Film Festival and wrote that his Instagram account carried posts on council business and on matches of FC Bayern Munich. The same article said the couple posted photographs of themselves only occasionally, usually from public events, and did not make a public theme of the marriage.
How the record is sourced and how the score is derived.
The score is formula-derived (Factrail formula v1, version 1.0.0), not an editorial verdict. Read the methodology.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute a fact on this pageNamed here, or represent someone who is? Request a right of reply.
People and organizations as listed in the Related section of this page; facts, drivers and the pages that name it as listed in the blocks here. Counts, not a rating.